Scarlet fever

AB1_SCARLET_FEVER

No definition available.

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — A38 Hospital discharge: ICD-9 — 03[4] Hospital discharge: ICD-8 — 03[4] Hospital discharge: excluded ICD-9 — 034[0] Hospital discharge: excluded ICD-8 — 034[0] Cause of death: ICD-10 — A38 Cause of death: ICD-9 — 03[4] Cause of death: ICD-8 — 03[4] Cause of death: excluded ICD-9 — 034[0] Cause of death: excluded ICD-8 — 034[0] 2 out of 7 registries used, show all original rules.	260
4. Check minimum number of events None	260
5. Include endpoints None	260
6. Filter based on genotype QC (FinnGen only)	260

Control definitions (FinnGen only)

Control exclude: AB1_OTHER_BACTERIAL

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF5

NAME	AB1_SCARLET_FEVER
CONTROL_EXCLUDE	AB1_OTHER_BACTERIAL
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	A38
HD_ICD_9	03[4]
HD_ICD_8	03[4]
HD_ICD_10_EXCL
HD_ICD_9_EXCL	034[0]
HD_ICD_8_EXCL	034[0]
COD_MAINONLY
COD_ICD_10	A38
COD_ICD_9	03[4]
COD_ICD_8	03[4]
COD_ICD_10_EXCL
COD_ICD_9_EXCL	034[0]
COD_ICD_8_EXCL	034[0]
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Scarlet fever based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	4075	1777	2286
Only index persons	3185	1380	1805
Unadjusted period prevalence (%)
Whole population	0.06	0.05	0.06
Only index persons	0.06	0.05	0.07
Median age at first event (years)
Whole population	7.01	6.65	7.16
Only index persons	7.59	7.19	7.90

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	260	145	115
Unadjusted period prevalence (%)	0.05	0.05	0.05
Median age at first event (years)	10.56	8.96	12.57

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

No data

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
225: Matched controls
2251

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

03419

ICD-8 Finland

Streptococcal sore throat and scarlet fever, Scarlatina NUD

+∞

93.4

A38

ICD-10 Finland

Scarlet fever

212.5

62.5

03417

ICD-8 Finland

Streptococcal sore throat and scarlet fever, Scarlatina suspecta

+∞

40.9

0341A

ICD-9 Finland

Streptococcal sore throat and scarlatina, Scarlatina[SCARLATINA STREPTOCOCCUS BETAHAEMOLYTICUS,RYHMÄ-A]

+∞

12.6

0341X

ICD-9 Finland

Streptococcal sore throat and scarlatina, Scarlatina[SCARLATINA STREPTOCOCCUS BETAHAEMOLYTICUS,MUU]

+∞

11.6

A49.9

ICD-10 Finland

Bacterial infection, unspecified

29.7

10.9

03410

ICD-8 Finland

Streptococcal sore throat and scarlet fever, Scarlatina cum complicatione

+∞

7.3

A46

ICD-10 Finland

Erysipelas

6.0

6.6

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

129

3.18

8.59

2.8

2.4

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

4.59

7.07

1.8

1.6

—

(3023368) Bacteria identified in Blood by Culture

302

2.14

5.55

4.1

3.1

—

(3030905) Polymorphonuclear cells [#/volume] in Blood

4.05

5.05

1.9

3.6

3.8

3.7

e9/l

0.08

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

4.05

5.05

1.9

3.7

54.9

54.6

0.04

(42870588) Differential panel, method unspecified - Blood

608

1.79

4.60

7.6

5.8

—

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

175

1397

1.77

4.44

8.2

6.2

76.4

75.3

u/l

0.13

165

1315

(3021589) Normoblasts [#/volume] in Blood

123

892

1.72

4.40

12.5

7.7

0.0

e9/l

0.80

103

735

(3032080) INR in Blood by Coagulation assay

533

1.79

4.29

6.1

5.5

1.1

inr

0.27

190

(40761536) Microorganisms panel - Urine sediment

156

2.28

4.22

4.8

2.7

—

(40767503) Oxygen content in Capillary blood by calculation

4.21

4.20

3.1

1.7

17.8

17.3

—

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

116

852

1.65

3.80

6.7

5.0

9.9

10.4

umol/l

0.28

107

817

(3024561) Albumin [Mass/volume] in Serum or Plasma

621

1.69

3.74

6.4

3.9

36.9

37.6

g/l

0.57

597

(3037522) Nuclear Ab [Titer] in Serum

290

1.85

3.43

1.5

1.4

146.7

603.8

titre

4.30

(3022145) Colonoscopy Study observation

192

1.95

3.07

1.5

1.4

—

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

670

1.58

2.97

5.6

4.8

1.2

mmol/l

1.12

621

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

4.82

2.94

1.6

1.8

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

2.32

2.88

1.5

1.4

—

(3013707) Erythrocyte sedimentation rate by Westergren method

171

1442

1.54

2.76

5.0

3.5

8.3

8.2

mm/h

0.02

158

1361

(3042936) Bacteria identified in Isolate by Culture

201

1.86

2.69

1.5

1.9

—

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

524

1.58

2.66

2.0

2.3

53.3

56.0

u/l

0.36

496

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

4.09

2.59

1.6

1.8

—

(3007853) Bacteria identified in Skin by Aerobe culture

197

1.84

2.55

1.6

1.4

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

4.46

2.49

1.6

1.7

—

(3029937) Albumin [Presence] in Urine by Test strip

488

1.56

2.48

5.2

2.9

0.0

estimate

0.50

176

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

455

1.57

2.44

1.5

1.7

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

5.09

2.41

2.0

1.6

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

4.20

2.37

1.1

1.9

—

(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count

560

1.50

2.25

3.0

2.5

—

(3013826) Glucose [Moles/volume] in Serum or Plasma

124

1009

1.44

2.19

4.8

3.6

6.6

6.4

mmol/l

0.46

112

923

(3027315) Oxygen [Partial pressure] in Blood

3.07

2.17

8.1

1.7

8.9

9.5

kpa

—

(3013290) Carbon dioxide [Partial pressure] in Blood

3.07

2.17

8.1

1.7

4.7

5.0

kpa

—

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

355

1.58

2.16

3.5

2.0

2.6

2.7

mg/l

0.17

304

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

264

1.66

2.15

1.8

1.6

417.1

27347379.0

pmol/l

0.50

245

(3021440) Promyelocytes/100 leukocytes in Blood

139

1.88

2.14

3.8

4.5

0.3

0.1

—

(3025159) Blasts/100 leukocytes in Blood

132

1.90

2.12

4.0

4.6

0.0

0.2

—

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

2.97

2.09

1.2

1.1

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

5.07

2.08

1.8

1.4

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

2.18

2.07

1.6

1.2

—

(3019309) Folate [Moles/volume] in Red Blood Cells

187

1.75

2.05

2.2

1.6

1452.4

1113.6

nmol/l

1.39

150

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

179

1569

1.45

2.05

4.6

3.8

14.6

14.4

pmol/l

0.51

165

1465

(3002179) Metamyelocytes/100 leukocytes in Blood

134

1.87

2.03

3.9

4.2

0.3

0.4

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

3.14

2.03

1.6

1.7

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

3.14

2.03

1.6

1.7

—

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

745

1.43

2.02

5.9

5.2

1.2

mmol/l

0.95

629

(3004588) Protein electrophoresis panel - Serum or Plasma

2.42

1.98

1.0

2.0

—

(3019198) Lymphocytes [#/volume] in Blood

125

1033

1.40

1.96

7.7

5.6

2.0

e9/l

0.35

115

926

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

4.61

1.95

2.4

1.6

—

(40768441) Liver Pathology biopsy report

4.61

1.95

1.6

1.1

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

557

1.46

1.94

2.9

2.8

21.0

23.7

ng/l

0.12

274

(3026782) Osmolality of Urine

307

1.56

1.88

2.7

2.0

483.0

569.7

mosm/kgh2o

1.27

249

(3001604) Monocytes [#/volume] in Blood

120

991

1.39

1.87

7.7

5.6

0.5

e9/l

0.03

110

877

(3017181) Myelocytes/100 leukocytes in Blood

146

1.79

1.85

3.8

4.3

1.6

0.4

—

(3006315) Basophils [#/volume] in Blood

120

993

1.39

1.84

7.8

5.7

0.0

e9/l

0.45

110

878

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

4.23

1.83

1.2

3.8

0.2

1.3

ug/l

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

404

1.49

1.81

1.4

1.8

0.7

0.9

mg/l

0.49

293

(3013115) Eosinophils [#/volume] in Blood

123

1024

1.38

1.81

8.0

5.8

0.2

e9/l

0.06

113

916

(3044889) 12 lead EKG panel

149

1281

1.38

1.79

3.3

2.9

—

(3010421) pH of Blood

2.55

1.75

8.3

1.7

7.4

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

3.39

1.75

2.0

1.4

—

(3015377) Calcium [Moles/volume] in Serum or Plasma

514

1.44

1.74

4.0

2.6

2.3

2.4

mmol/l

0.69

464

(1616796) Gas panel - Central venous blood

2.63

1.67

8.9

2.0

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

2.85

1.66

1.4

1.3

—

(3018418) pH of Serum or Plasma

447

1.44

1.65

4.4

3.1

7.4

0.51

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

2.38

1.62

1.1

1.3

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

2.55

1.61

1.3

1.2

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

185

1.64

1.60

1.3

1.6

—

(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood

3.05

1.59

1.0

1.3

—

(3026008) Bacteria identified in Urine by Culture

408

1.44

1.55

2.4

2.2

—

(3004789) Transferrin [Mass/volume] in Serum or Plasma

179

1.63

1.53

3.6

1.7

2.5

g/l

0.09

169

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

3.38

1.53

2.2

1.5

—

(3019550) Sodium [Moles/volume] in Serum or Plasma

217

2014

1.47

1.50

12.5

8.9

139.4

139.8

mmol/l

1.66

210

1965

(3023520) Reticulocytes [#/volume] in Blood

1.93

1.48

3.2

3.0

62.0

71.1

e9/l

—

(3044640) Blood type and Crossmatch panel - Blood

511

1.39

1.46

1.7

1.8

—

(3042631) Mycobacterium sp identified in Specimen

3.16

1.44

1.6

2.2

—

(3021788) Differential panel - Synovial fluid

2.77

1.44

1.5

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

127

1.71

1.41

2.7

2.4

15269.3

3637.8

u/l

0.37

(40768793) Breast Pathology biopsy report

2.24

1.38

1.1

1.2

—

(4035726)

105

1.77

1.37

1.2

1.3

—

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

203

1872

1.38

1.36

12.0

7.8

92.3

92.5

ml/min/173m2

0.07

169

1513

(3009343) pH of Capillary blood

113

1.74

1.36

4.2

2.9

7.4

—

(3030467) Casts [#/volume] in Urine by Automated count

437

1.39

1.34

3.0

2.3

0.1

0.3

e6/l

1.14

309

(46235355) HIV 1 and 2 tests - Meaningful Use set

575

1.35

1.31

1.7

2.0

—

(3035637) Corticotropin [Mass/volume] in Plasma

2.53

1.31

1.7

1.5

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

2.81

1.29

2.4

3.4

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

196

1.54

1.28

1.6

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

764

1.32

1.28

4.6

2.7

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

101

850

1.31

1.28

3.8

3.4

—

(3026493) Urate [Moles/volume] in Serum or Plasma

432

1.38

1.27

2.3

5807.7

1361.8

umol/l

0.37

396

(36304419) Bacteria [Presence] in Urine

443

1.37

1.23

3.0

2.3

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

390

1.38

1.22

1.7

—

(3023103) Potassium [Moles/volume] in Serum or Plasma

216

2027

1.39

1.18

12.8

8.9

3.9

mmol/l

0.09

207

1969

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

1.85

1.17

1.2

1.5

—

(3052851) Hemolysis interference index of Serum or Plasma

2.08

1.16

4.0

2.0

—

(3037467) Urinalysis macro (dipstick) panel - Urine

148

1321

1.28

1.16

5.5

3.4

—

(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum

2.53

1.15

1.2

1.3

—

(3035350) Ketones [Presence] in Urine by Test strip

111

958

1.28

1.13

4.4

2.8

0.0

estimate

0.00

173

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

350

1.38

1.13

1.4

1.2

2.2

6.6

u/ml

1.30

149

(3021601) Nitrite [Presence] in Urine by Test strip

111

960

1.27

1.11

5.4

4.0

0.0

estimate

0.00

182

(3009261) Glucose [Presence] in Urine by Test strip

112

973

1.27

1.07

4.4

2.8

0.1

0.0

estimate

0.49

171

(3002582) Erythrocytes [#/volume] in Urine

492

1.31

1.04

3.1

2.4

11.4

42.8

e6/l

1.59

360

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

367

1.34

0.99

1.4

1.3

30.6

29.8

iu/ml

0.02

122

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

2.20

0.98

3.4

2.8

13.8

19.3

u/ml

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

0.00

0.98

0.0

1.0

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

175

1.47

0.97

1.2

1.3

200.0

185.1

iu/ml

0.04

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

714

1.26

0.95

3.2

2.4

74.7

72.5

nmol/l

0.34

662

(40760892) CBC W Ordered Manual Differential panel - Blood

498

1.29

0.95

4.5

4.0

—

(40768443) Skin Pathology biopsy report

1.75

0.94

1.2

1.1

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

1.76

0.93

1.1

1.2

—

(3022313) Gas panel - Capillary blood

1.66

0.93

4.0

3.1

—

(3013650) Neutrophils [#/volume] in Blood by Automated count

128

1144

1.23

0.92

9.6

8.0

4.0

3.9

e9/l

0.35

119

999

(4268621)

2.17

0.92

2.2

2.3

—

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

1.72

0.90

1.6

2.2

—

(40761535) Cells panel - Urine sediment

103

1.59

0.90

2.6

2.9

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

232

2225

1.40

0.89

11.6

8.0

30.2

29.1

u/l

0.37

222

2172

(4306422)

1.89

0.88

1.1

1.2

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

137

1.50

0.87

1.4

1.5

—

(3003694) ABO and Rh group [Type] in Blood

627

1.25

0.86

1.6

1.5

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

138

1.49

0.84

1.5

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

497

1.27

0.84

1.6

1.7

1.5

mmol/l

0.35

443

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

1.72

0.83

8.5

6.2

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

405

1.29

0.83

4.2

2.9

—

(3025941) Bacteria identified in Stool by Culture

122

1.51

0.82

1.1

1.2

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

1.90

0.82

1.2

1.1

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

324

1.32

0.81

1.4

1.6

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

0.00

0.79

0.0

1.3

—

(3014051) Protein [Presence] in Urine by Test strip

1.84

0.79

1.5

—

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1.78

0.77

1.0

2.3

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

197

1861

1.24

0.76

5.2

4.4

1.7

2.4

mu/l

0.54

186

1762

(3000991) Gas panel - Venous blood

116

1.50

0.76

7.6

6.6

—

(3021901) Oxygen saturation in Capillary blood

2.10

0.75

4.0

1.7

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

1.66

0.74

1.1

1.2

—

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

1.66

0.74

1.1

—

(3023511) Choriogonadotropin [Units/volume] in Urine

1.58

0.73

1.4

1.3

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

1.82

0.73

1.7

1.2

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

1.94

0.71

1.0

1.2

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

1.94

0.71

1.0

1.2

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

214

0.68

0.69

1.1

1.4

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

1.87

0.69

1.0

2.2

0.0

g/l

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

1.87

0.69

1.0

2.2

0.0

g/l

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

1.64

0.67

1.1

—

(3015736) pH of Urine

750

1.20

0.66

3.8

2.6

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

218

2093

1.26

0.66

13.2

9.0

21.5

19.3

mg/l

0.43

180

1552

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

164

1.37

0.65

3.8

6.3

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

190

1801

1.20

0.64

3.3

3.6

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

1.74

0.64

1.0

2.5

0.0

1.5

g/l

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

1.74

0.64

1.0

2.3

0.0

g/l

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

373

1.25

0.64

1.5

—

(3034770) Mitochondria Ab [Titer] in Serum

1.61

0.62

1.4

1.2

—

(3002385) Erythrocyte distribution width [Ratio]

195

1855

1.20

0.62

15.3

11.1

13.4

0.10

189

1828

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

1.68

0.61

1.4

1.1

—

(40758558) Short blood count panel - Blood

478

1.22

0.61

7.3

5.8

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

0.00

0.60

0.0

1.4

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

194

1.32

0.58

1.7

2.0

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

1.50

0.58

1.6

1.8

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

1.73

0.58

1.0

2.3

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

1.73

0.58

1.0

1.1

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

249

1.28

0.57

1.9

2.1

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

548

1.20

0.57

1.4

1.3

0.5

1.3

u/ml

2.01

161

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

294

0.76

0.57

1.4

1.7

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

1.56

0.56

1.0

1.1

1.3

5.2

u/ml

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

1.59

0.54

1.0

—

(3007164) IgA [Mass/volume] in Serum or Plasma

494

1.20

0.54

1.5

1.3

2.3

2.2

g/l

0.12

315

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

183

1914

0.85

0.53

3.8

3.5

5.9

5.7

mmol/l

0.64

169

1810

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

1.55

0.53

1.2

1.1

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

252

1.26

0.53

2.2

1.8

—

(3018095) Leukocytes [#/volume] in Urine

602

1.18

0.51

3.6

3.0

27.8

152.1

e6/l

0.94

392

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

195

2025

0.85

0.49

3.9

3.6

1.4

mmol/l

0.78

184

1943

(4010399)

128

1.35

0.49

1.5

1.4

—

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

1.50

0.48

2.1

2.8

3.6

3.1

g/l

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

1.49

0.47

1.4

1.8

—

(3021960) Folate [Moles/volume] in Serum or Plasma

330

1.21

0.47

1.5

1.3

19.0

20.4

nmol/l

0.23

294

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

361

0.81

0.47

1.4

1.6

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

1.47

0.47

1.1

1.9

—

(3012544) pH of Venous blood

129

1.34

0.47

3.4

4.1

—

(3041096) Erythrocytes [Presence] in Urine by Automated

587

1.17

0.47

4.0

2.4

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

1.44

0.46

1.1

1.9

—

(21494755) Public health laboratory ask at order entry panel

379

0.82

0.44

1.3

1.4

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

1.44

0.43

1.0

1.4

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

250

1.23

0.42

1.8

2.4

2.2

2.5

e6/l

0.09

129

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

1.57

0.42

1.0

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

186

1.26

0.42

1.5

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

1.39

0.42

1.3

1.4

—

(40765089) Chromosome analysis panel - Blood by G-banded

0.00

0.41

0.0

1.0

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

0.00

0.41

0.0

1.6

—

(4198724)

0.00

0.40

0.0

1.8

—

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

0.00

0.40

0.0

1.2

—

2.5

—

(3014576) Chloride [Moles/volume] in Serum or Plasma

160

1.27

0.40

7.0

5.8

103.2

104.5

mmol/l

0.45

153

(3001019) Free T4 and TSH panel - Serum or Plasma

170

0.75

0.39

2.2

1.8

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

1.38

0.39

1.2

1.4

—

(3013512) EKG study

385

1.17

0.38

3.3

2.8

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

577

1.14

0.38

1.7

91.9

96.2

pmol/l

0.39

305

(3048929) Epstein Barr virus Ab [Presence] in Serum

107

1.33

0.38

1.1

1.3

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

1.33

0.36

1.7

—

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

1.44

0.36

1.0

1.1

122.3

114.5

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

590

1.14

0.35

1.8

1.6

—

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

1.40

0.35

1.7

1.3

—

(40761511) CBC panel - Blood by Automated count

228

2232

1.17

0.33

12.9

8.2

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

110

1.29

0.32

2.1

1.6

294.1

347.0

mu/l

0.27

100

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

164

1576

1.11

0.32

3.6

2.8

42.1

u/l

0.00

155

1527

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

292

0.84

0.31

1.8

2.2

0.7

0.6

ug/l

—

134

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

129

1.26

0.31

2.3

2.2

63.1

81.2

ml/min/173m2

—

(3019225) pH of Specimen

120

1.27

0.31

3.4

3.3

—

(40768804) Tissue Pathology biopsy report

713

1.11

0.30

1.8

1.9

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

1.31

0.28

1.0

1.3

—

(1761868) Lipid panel - Serum or Plasma

100

943

1.10

0.28

2.8

2.3

—

(3048689) Calprotectin [Mass/mass] in Stool

320

1.15

0.27

4.4

2.6

114.6

72.2

ug/g

0.40

250

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

182

1766

1.10

0.27

4.7

4.1

38.8

38.2

mmol/mol

0.31

170

1697

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

171

0.81

0.27

3.4

3.3

35.3

30.1

—

125

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

1.29

0.26

1.4

1.7

—

(3000330) Specific gravity of Urine by Test strip

1.24

0.25

1.7

1.9

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

428

1.12

0.25

2.4

2.1

—

(3000764) Benzodiazepines [Presence] in Urine

180

0.82

0.25

2.5

2.0

—

(3020682) Albumin/Creatinine [Ratio] in Urine

409

1.12

0.25

4.3

3.5

9.7

7.9

mg/mmol

0.12

275

(3050129) First trimester maternal screen panel - Serum or Plasma

126

0.79

0.24

1.8

1.4

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

256

1.15

0.24

1.9

2.3

0.2

1.0

e6/l

2.17

135

(3028300) Cannabinoids [Presence] in Urine

179

0.83

0.24

3.2

2.1

—

(3027944) Amphetamines [Presence] in Urine

179

0.83

0.24

2.5

1.8

—

(3027008) Opiates [Presence] in Urine

179

0.83

0.24

2.5

2.0

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

200

2043

0.91

0.23

4.2

3.8

2.8

2.9

mmol/l

0.61

186

1952

(3012516) Albumin [Mass/volume] in Urine

392

1.12

0.23

3.1

2.8

114.7

218.2

mg/l

0.24

263

(3008898) HLA-B27 [Presence]

125

1.21

0.23

1.1

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

0.00

0.21

0.0

1.2

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

0.00

0.21

0.0

2.5

—

(4024509)

0.00

0.21

0.0

1.5

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

0.00

0.21

0.0

1.0

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

0.00

0.21

0.0

1.2

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

1509.2

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

0.00

0.21

0.0

1.9

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

0.00

0.21

0.0

7.1

—

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

0.00

0.21

0.0

1.3

—

1.7

—

(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma

0.00

0.21

0.0

1.1

—

214.1

—

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

0.00

0.21

0.0

10.8

—

56.0

—

(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay

0.00

0.21

0.0

1.0

—

26.5

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

0.00

0.20

0.0

1.4

—

(3005570) Glucose [Moles/volume] in Urine

0.00

0.20

0.0

1.9

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

0.00

0.20

0.0

1.0

—

(3016018) Differential panel - Cerebral spinal fluid

0.00

0.20

0.0

2.1

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

464

1.10

0.19

2.6

2.2

—

(40768797) Stomach Pathology biopsy report

232

1.13

0.19

1.1

1.2

—

(36660697) Celiac disease serology panel - Serum

204

1.14

0.18

1.2

1.1

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

153

0.84

0.18

1.2

1.3

—

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

1.17

0.18

3.6

4.0

1.1

1.7

—

(42529406) Shigella sp [Presence] in Stool by Culture

0.75

0.17

1.0

1.2

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

0.75

0.17

1.0

1.2

—

(3019150) Specific gravity of Urine by Refractometry

448

1.09

0.17

5.2

2.8

1.0

kg/l

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

192

1954

0.93

0.16

3.6

3.3

1.5

1.3

mmol/l

1.33

180

1866

(3003327) Ova and parasites identified in Stool by Light microscopy

1.10

0.16

1.9

1.5

—

(3028707) Methadone [Presence] in Urine by Screen method

1.16

0.15

2.2

2.6

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

1.16

0.15

1.2

1.3

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

1.20

0.14

1.0

1.1

—

(3019832) Treponema pallidum Ab [Presence] in Serum

355

1.08

0.13

1.5

1.7

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

108

0.83

0.13

1.6

1.5

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

127

0.86

0.12

2.8

1.9

—

(3022621) pH of Urine by Test strip

104

1.16

0.12

5.9

2.0

—

(1002224) Polysomnography panel

135

0.88

0.10

1.2

1.1

—

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

291

1.07

0.10

3.5

2.8

1437.5

558.5

ng/l

0.58

231

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

1.04

0.09

2.4

1.4

—

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

1.11

0.09

1.0

1.1

—

14.0

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

1.07

0.08

1.0

1.2

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

273

1.07

0.08

1.8

2.9

893.7

276.7

ng/l

0.48

165

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

1.04

0.08

1.0

1.1

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

1.04

0.08

2.5

2.1

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

0.78

0.08

1.0

1.2

—

(3016879) Cocaine [Presence] in Urine

164

0.91

0.08

2.5

2.1

—

(4034850)

1.06

0.08

5.1

7.5

—

(3009542) Hematocrit [Volume Fraction] of Blood

211

2091

1.05

0.08

11.7

9.7

41.2

41.3

0.09

167

1800

(3045414) Leukocytes [Presence] in Urine

1.04

0.07

1.9

1.4

—

(3000492) Spirometry study

227

1.06

0.06

1.7

1.4

—

(3000494) Fungus identified in Specimen by Culture

212

0.94

0.05

1.3

1.4

—

(3002256) Pathology report gross observation

222

0.94

0.05

1.2

—

(3009508) Creatinine [Moles/volume] in Urine

516

1.03

0.05

3.0

2.7

9.1

9.0

mmol/l

0.04

463

(3001122) Ferritin [Mass/volume] in Serum or Plasma

925

1.03

0.04

3.3

2.4

99.4

95.1

ug/l

0.08

878

(3010813) Leukocytes [#/volume] in Blood

242

2428

0.95

0.02

18.9

13.5

7.5

6.5

e9/l

0.66

235

2372

(3011288) Drugs identified in Urine by Screen method

117

0.94

0.02

3.2

3.0

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

137

0.95

0.01

2.5

2.3

—

(3026361) Erythrocytes [#/volume] in Blood

242

2427

0.96

0.01

18.9

13.4

4.6

e12/l

1.04

235

2376

(3013139) Helicobacter pylori Ag [Presence] in Stool

132

0.98

0.00

1.1

1.2

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

372

0.99

0.00

1.5

1.8

1.3

1.4

0.09

354

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

203

2032

1.00

0.00

3.9

3.6

4.7

4.8

mmol/l

0.64

189

1954

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

144

0.97

0.00

1.0

—

(3007461) Platelets [#/volume] in Blood

242

2424

0.98

0.00

18.9

13.4

259.8

257.1

e9/l

0.28

235

2375

(3014271) Vancomycin [Susceptibility]

0.00

0.0

2.6

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

0.00

0.0

1.2

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

0.00

0.0

1.4

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

0.00

0.0

1.4

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

0.00

0.0

1.0

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

0.00

0.0

1.2

—

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

0.00

0.0

1.0

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

0.99

0.00

1.4

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

0.00

0.0

1.0

—

(3004959) Base excess in Arterial cord blood by calculation

0.00

0.0

1.0

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

0.00

0.0

1.0

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

0.00

0.0

1.0

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

0.00

0.0

1.0

—

(3022689) Creatine [Moles/volume] in Urine

0.00

0.0

1.4

—

(3002619) Bacteria identified in Specimen by Culture

0.00

0.0

1.0

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

0.00

0.0

1.2

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

0.00

0.0

1.0

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

0.00

0.0

1.2

—

(3006598) pH of Arterial cord blood

0.00

0.0

1.0

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

0.00

0.0

1.0

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

0.00

0.0

1.1

—

(4133840)

0.00

0.0

1.0

—

(3019060) Gas panel - Arterial blood

1.01

0.00

1.9

3.1

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

0.96

0.00

1.0

1.1

—

9.1

—

(3037556) Urate [Mass/volume] in Serum or Plasma

0.00

0.0

1.0

—

(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum

0.00

0.0

1.2

—

20.6

—

(3005033) Fetal Nuchal fold Thickness US

0.97

0.00

1.5

1.4

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

0.95

0.00

1.6

1.4

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

0.00

0.0

1.1

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

0.00

0.0

1.0

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

0.00

0.0

1.0

—

(3013637) Mi-2 Ab [Presence] in Serum

0.00

0.0

1.0

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

0.94

0.00

1.5

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

0.00

0.0

2.4

—

(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma

0.00

0.0

1.3

—

619.2

—

(3020650) Glucose [Presence] in Urine

0.00

0.0

1.6

—

(3014007) Fractional oxyhemoglobin in Arterial blood

0.96

0.00

12.6

7.9

91.4

94.2

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

1.0

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

0.00

0.0

1.0

—

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

0.92

0.00

11.9

7.7

1.3

1.6

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

0.95

0.00

1.6

1.4

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

0.00

0.0

2.4

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

0.00

0.0

1.1

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

0.97

0.00

1.5

1.4

—

(40765096) Chromosome analysis panel by Banding

0.00

0.0

1.0

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

1.00

0.00

2.8

1.9

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

0.00

0.0

1.0

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

0.00

0.0

1.2

—

(3016038) Potassium [Moles/volume] in Urine

0.00

0.0

1.7

—

38.0

—

(3004119) Hemoglobin [Mass/volume] in Venous blood

1.01

0.00

4.3

3.7

124.6

139.4

g/l

—

(3043410) Blood group antigens tested for on Red Blood Cells

0.00

0.0

1.3

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

0.00

0.0

1.0

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

0.00

0.0

1.0

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

1.0

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

1.0

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

1.0

—

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

0.00

0.0

1.0

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

0.95

0.00

1.6

1.4

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

0.95

0.00

1.6

1.4

—

(3030981) Hyaline casts [#/volume] in Urine by Automated count

0.93

0.00

2.1

2.0

0.1

e6/l

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

1.02

0.00

1.5

1.3

—

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

0.93

0.00

12.3

7.8

0.8

0.7

—

Mortality – FinRegistry

↥

Association

Association between endpoint AB1_SCARLET_FEVER and mortality.

Females

No data

Males

No data

Mortality risk

Mortality risk for people of age

years, who have AB1_SCARLET_FEVER.

N-year risk	Females	Males
1	No data	No data
5	No data	No data
10	No data	No data
15	No data	No data
20	No data	No data

Relationships between endpoints

↥

Index endpoint: AB1_SCARLET_FEVER – Scarlet fever

GWS hits: 1

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Scarlet fever

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints